UCB (EBR:UCB) UCB Media Room: Disposals of own shares

Transparency directive : regulatory news

03/07/2020 20:00

https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513= 9PTmAm2ORJ-2Fb7C-2B6eklp-2FbEFWS4DMSK582JWwKBKbslaZiTFdDiv0wZackig0mUbzgP45= nBtSiXoXlEFqJpXxppbiUfwqcqrs2D9XM5fV5j_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7= KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1= wbi59sU7B6jvxaPVXVfmFrXor24MnFQmjS3qUpkJRcuxwFCRqxXofzGBBZaHSa8c44i1wBmglbg= d0Ebz1ezfx9di3enW-2BYh9Aj6Ovk-2BVNm6JCNf6tOACQ-2FUaLFXivEXyvEonkdKIANJkeINW= WU2JNkcjPlJbmApH4-2BTTCFg38tPUvOSBSy5J64zqT16au5Q4F6vurpnReUD3KgwvHRdKY1-2F= JbUYorvLS9e-2FLfxBEX99O2NXjIKUbiBRVbPO4PPBfUA-3D ** Disposals of own shares ------------------------------------------------------------ Brussels (Belgium), 3 July 2020 =E2=80=93 20:00 (CEST) =E2=80=93 regulated = information In accordance with article 8:6 of the Royal Decree executing the Belgian Co= de of Companies and Associations, UCB announces that, following exercises o= f stock options by members of its personnel, it has disposed of UCB shares = OTC in view of deliveries of these shares to the relevant members of the pe= rsonnel, within the framework of the Long Term Incentive Program of the UCB= Group, as follows:=C2=A0 https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513= 9PTmAm2ORJ-2Fb7C-2B6eklp-2FbEFWS4DMSK582JWwKBay7z1sgnPOFulMvls-2BmTcEi6TfXm= nFeUx3FMeNAlIH2DeL8lj4OltLXlonQdAh2e6raH_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVW= u7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9= g1wbi59sU7B6jvxaPVXVfmFrXor24MnFQmjS3qUpkJRcuxwFCRqxXofzGBBZaHSa8c44i1wBmgl= bgd0Ebz1ezfx9di3enW-2BYh9Aj6Ovk-2BVNm6JFUVg4EJr5nFZir2Q5unaTXkjrZwG8n8hryhp= ZT1JqO9306kZapddR0E12rq5iKYa-2F4YD0OIeiLtNGoDl6CXIqNoKoVpLnFhIOQmW7FYebyPXD= 3fgDOP2gn07ESvBj8hqS7EAfFIqY0NstHCjuio4fo-3D This press release is available on UCB SA/NV=E2=80=99s website via the foll= owing link (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQ= yQ53jATUXZJD59ZUodhGC-2FyJVE-2BjXw-2Fd0j1C70r-2FZ058zOLCiGbx-2FzvKhSzxYKNx1= 8dK5MiuQ-3D-3DddJh_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bS= l0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wbi59sU7B6jvxaPVXVfm= FrXor24MnFQmjS3qUpkJRcuxwFCRqxXofzGBBZaHSa8c44i1wBmglbgd0Ebz1ezfx9di3enW-2B= Yh9Aj6Ovk-2BVNm6JKWIPg85u7eKD8x1H5QhjK2cgXhNH2ssZZ5zl-2FWu-2FiT-2FZF5Qwiu3V= FdJIet-2FrwhJgOsxwc3pTzZPBFZ6a2nHcEZJLezlKGCT4kgTdYQ5htWusJRdnxlu0tjlHNbtFV= i-2FmXFQydJ-2BIYqu-2FjJtTNPEhq4-3D . Investor Relations Antje Witte =C2=A0 =C2=A0 =C2=A0 =C2=A0 =C2=A0 Investor Relations, UCB T +32.2.559.94.14 antje.witte@ucb.com Isabelle Ghellynck, =C2=A0Investor Relations, UCB T+32.2.559.9588, isabelle.ghellynck@ucb.com=C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With 7 500 people in approxima= tely 40 countries, the company generated revenue of =E2=82=AC 4.9 billion i= n 2019. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twit= ter: @UCB_news =C2=A0 GenericFile 200703 - UCB Disposals of own shares (https://u7061146.ct.sendgrid.net/ls/c= lick?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6eklp-2FbEFWS4DMSK= 582JWwKB15YehWu-2B-2FRruXzMlZxfEQxZdOlAwi69ALTyOpgjNnCg-3DBUc5_xDPID0vOuylF= AU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2= FOeoCOG9ekocVj-2F2X9c9g1wbi59sU7B6jvxaPVXVfmFrXor24MnFQmjS3qUpkJRcuxwFCRqxX= ofzGBBZaHSa8c44i1wBmglbgd0Ebz1ezfx9di3enW-2BYh9Aj6Ovk-2BVNm6JCT2HWvz4ngkFOy= AUXuiy-2FR5ggxT3mMJ4Jqs26JvYMxIlqX4dOcOmrEZn8BLr6q33xwcwqm-2B0-2FNge1aWIC5r= VqEgx192gTe-2FhsO5u2Rv1kbidQ3mDNp4WF8iBOx6bA2OwpbcsC7aPP3tZPbEFo5O3Nc-3D Ge= nericFile 200703 - Rachat et Ali=C3=A9nation d actions propres (https://u7061146.ct.s= endgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6e= klp-2FbEFWS4DMSK582JWwKB1p1HY7o75ztVLzcSZJpgHAIWxPTquD0H7sA5l-2Fre3CI-3DeTs= P_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-= 2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wbi59sU7B6jvxaPVXVfmFrXor24MnFQmjS3qU= pkJRcuxwFCRqxXofzGBBZaHSa8c44i1wBmglbgd0Ebz1ezfx9di3enW-2BYh9Aj6Ovk-2BVNm6J= ABVQWULM4-2BvR4-2F8lrg5SC-2FpgVW4KXEuo8L-2B0aHR9-2BJ34qIhgfEdN-2B-2BMDQZsBs= VKj6rWeaEIF4HWCvyH21Z-2Bw3jiaN8qEMfHbK7OGEQ7XT8A2q9EKpszrnc368RdQA1F9JzxnPD= 44l1QaHR0HHf0x50-3D GenericFile 200703 - Verwerving en vervreemding van eigen aandelen (https://u7061146.ct= .sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B= 6eklp-2FbEFWS4DMSK582JWwKBswsxW3vsQ74o9EczbmCl03vhwsPlyxeOZPVofFi0LNs-3D33X= p_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-= 2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wbi59sU7B6jvxaPVXVfmFrXor24MnFQmjS3qU= pkJRcuxwFCRqxXofzGBBZaHSa8c44i1wBmglbgd0Ebz1ezfx9di3enW-2BYh9Aj6Ovk-2BVNm6J= BJOzb3AmPEr5Fg8ftIHHva1SXPJIH9JGkK88tWJ2uSA9Vq-2Fd0XICyUNChvwyJSPx-2Fnao-2F= TAts8VhAxvP9TtUn1-2FRvx-2FLoRvDSWs-2Bxh-2Bhoa6CLVYS7rHwVQ8gRLmT4uNwea-2BsXH= eqbIw-2BhrTrmbwDO8-3D Image Chart 1 July 3 2020 (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-= 2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6eklp-2FbEFWS4DMSK582JWwKBay7z1sgnP= OFulMvls-2BmTcOluoTXMSQ8J93FC681wECg-3DsYAj_xDPID0vOuylFAU8fv4e60wei4JxqEGB= dVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X= 9c9g1wbi59sU7B6jvxaPVXVfmFrXor24MnFQmjS3qUpkJRcuxwFCRqxXofzGBBZaHSa8c44i1wB= mglbgd0Ebz1ezfx9di3enW-2BYh9Aj6Ovk-2BVNm6JBsvTCXjz0YTdeC75ZT9Y1gVnltRKYRcBD= O5Wg5FGzqoCGELi8tdTJBc0-2BrYUkjV-2Fqdt-2Fclm5QPMbGT24yLzC3RbbNg-2BAd-2BqHnJ= LSKS1Bv8tck6icabp663jcKbNorb-2F51fH06-2FptVGx8aMivanU0vs-3D=0D =0D ______________________=0D If you would rather not receive future communications from UCB SA, please g= o to https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jAT= UeYfdhr1xEBQnaPhR2RKx1tfe2VKDZTewv5u80JomRcXRnZ-2BfWjoTlWxgckNkJmPbGxbwy-2F= P2Me62TwITdrARuZybUSrvnR8sn2Ju6gPh7zkHXAbFvFhXenVTgKxHz48QHSx3FomkswSh4-2Ba= VjyLaes-3DcSpQ_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0Kx= vPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1wbi59sU7B6jvxaPVXVfmFrXo= r24MnFQmjS3qUpkJRcuxwFCRqxXofzGBBZaHSa8c44i1wBmglbgd0Ebz1ezfx9di3enW-2BYh9A= j6Ovk-2BVNm6JBH0gDQwy-2FJmToEDG4e0n31bZERCCD3fhCawa09qM3AKdKpPzx1grDlOFQL5W= -2BsvE4hC-2BHZmzRv7an08e-2BwpEcakiKgMR5PmkyeBXgpf855AjvF4RGR-2FgY2Xcwg2Vj62= ICs-2F-2BigleKcH6hgY-2Bk9j-2FCw-3D=0D UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=

UCB's latest news

17/04/2024 07:01

UCB (EBR:UCB) UCB Media Room: Disposals of own shares

Transparency directive : regulatory news

UCB's latest news

Other stories